Related references
Note: Only part of the references are listed.Clinical and Biological Implications of Cancer Stem Cells in Hepatocellular Carcinoma
Hiroyuki Tsuchiya et al.
YONAGO ACTA MEDICA (2021)
Acetylcholine promotes the self-renewal and immune escape of CD133+thyroid cancer cells through activation of CD133-Akt pathway
Zhenglin Wang et al.
CANCER LETTERS (2020)
Inhibition of DCLK1 down-regulates PD-L1 expression through Hippo pathway in human pancreatic cancer
Rui Yan et al.
LIFE SCIENCES (2020)
Cancer Stem Cell Marker DCLK1 Correlates with Tumorigenic Immune Infiltrates in the Colon and Gastric Adenocarcinoma Microenvironments
Xiangyan Wu et al.
CANCERS (2020)
Influence of the Tumor Microenvironment on NK Cell Function in Solid Tumors
Ombretta Melaiu et al.
FRONTIERS IN IMMUNOLOGY (2020)
NEAT1 is Required for the Expression of the Liver Cancer Stem Cell Marker CD44
Shigemi Koyama et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Human Hepatic Cancer Stem Cells (HCSCs) Markers Correlated With Immune Infiltrates Reveal Prognostic Significance of Hepatocellular Carcinoma
Xiaopu Sang et al.
FRONTIERS IN GENETICS (2020)
Glioma stem-like cells evade interferon suppression through MBD3/NuRD complex-mediated STAT1 downregulation
Xiaoyan Zhan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
The human tumor microbiome is composed of tumor type-specific intracellular bacteria
Deborah Nejman et al.
SCIENCE (2020)
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion
Rui Su et al.
CANCER CELL (2020)
Galectin-3 in Prostate Cancer Stem-Like Cells Is Immunosuppressive and Drives Early Metastasis
Sara Caputo et al.
FRONTIERS IN IMMUNOLOGY (2020)
The Role of Proteoglycans in Cancer Metastasis and Circulating Tumor Cell Analysis
Theresa D. Ahrens et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2020)
CD200 expression marks leukemia stem cells in human AML
Jenny M. Ho et al.
BLOOD ADVANCES (2020)
Harnessing stemness and PD-L1 expression by AT-rich interaction domain-containing protein 3B in colorectal cancer
Tsai-Tsen Liao et al.
THERANOSTICS (2020)
Synthetic and immunological studies on the OCT4 immunodominant motif antigen-based anti-cancer vaccine
Tingting Chen et al.
CANCER BIOLOGY & MEDICINE (2020)
C/EBPδ links IL-6 and HIF-1 signaling to promote breast cancer stem cell-associated phenotypes
Kuppusamy Balamurugan et al.
ONCOGENE (2019)
Insluin and epithelial growth factor (EGF) promote programmed death ligand 1(PD-L1) production and transport in colon cancer stem cells
Mingshui Chen et al.
BMC CANCER (2019)
Induction of tolerogenic dendritic cells by activated TGF-/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells
Ming Zhong et al.
BMC CANCER (2019)
PD-L1 promotes colorectal cancer stem cell expansion by activating HMGA1-dependent signaling pathways
Fang Wei et al.
CANCER LETTERS (2019)
Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non-Small Cell Lung Cancer
Mengjia Song et al.
CANCER RESEARCH (2019)
Accumulation of Circulating CCR7+ Natural Killer Cells Marks Melanoma Evolution and Reveals a CCL19-Dependent Metastatic Pathway
Costanza Maria Cristiani et al.
CANCER IMMUNOLOGY RESEARCH (2019)
Low CD8+ T Cell Infiltration and High PD-L1 Expression Are Associated with Level of CD44+/CD133+ Cancer Stem Cells and Predict an Unfavorable Prognosis in Pancreatic Cancer
Ya-Chin Hou et al.
CANCERS (2019)
Killer Ig-Like Receptors (KIRs): Their Role in NK Cell Modulation and Developments Leading to Their Clinical Exploitation
Daniela Pende et al.
FRONTIERS IN IMMUNOLOGY (2019)
Effect of Tumor Burden on Tumor Aggressiveness and Immune Modulation in Prostate Cancer: Association with IL-6 Signaling
Chun-Te Wu et al.
CANCERS (2019)
The JAK2/STAT3/CCND2 Axis promotes colorectal Cancer stem cell persistence and radioresistance
So-Yeon Park et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2019)
Extracellular Matrix Alterations in Metastatic Processes
Mayra Paolillo et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Galectin-3 modulation of T-cell activation: mechanisms of membrane remodelling
Rebecca C. Gilson et al.
PROGRESS IN LIPID RESEARCH (2019)
Safety and Tolerability of Anti-Angiogenic Protein Kinase Inhibitors and Vascular-Disrupting Agents in Cancer: Focus on Gastrointestinal Malignancies
Letizia Procaccio et al.
DRUG SAFETY (2019)
ALDH3A1 Overexpression in Melanoma and Lung Tumors Drives Cancer Stem Cell Expansion, Impairing Immune Surveillance through Enhanced PD-L1 Output
Erika Terzuoli et al.
CANCERS (2019)
Catumaxomab with Activated T-cells Efficiently Lyses Chemoresistant EpCAM-positive Triple-negative Breast Cancer Cell Lines
Makoto Kubo et al.
ANTICANCER RESEARCH (2018)
Reduction of MHC-I expression limits T-lymphocyte-mediated killing of Cancer-initiating cells
Brian J. Morrison et al.
BMC CANCER (2018)
Cancer Stemness, Immune Cells, and Epitheliale-Mesenchymal Transition Cooperatively Predict Prognosis in Colorectal Carcinoma
Fangying Xu et al.
CLINICAL COLORECTAL CANCER (2018)
Single-cell analysis reveals cancer stem cell heterogeneity in hepatocellular carcinoma
Hongping Zheng et al.
HEPATOLOGY (2018)
Expression of ALCAM (CD166) and PD-L1 (CD274) independently predicts shorter survival in malignant pleural mesothelioma
Shingo Inaguma et al.
HUMAN PATHOLOGY (2018)
Quiescent Tissue Stem Cells Evade Immune Surveillance
Judith Agudo et al.
IMMUNITY (2018)
Retrospective analysis on the efficacy of sunitinib/sorafenib in combination with dendritic cells-cytokine-induced killer in metastasis renal cell carcinoma after radical nephrectomy
Hai-Xing Mai et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
Aggressive serous epithelial ovarian cancer is potentially propagated by EpCAM+CD45+ phenotype
Md Zahid Akhter et al.
ONCOGENE (2018)
Epigenetic Silencing of TAP1 in Aldefluor+ Breast Cancer Stem Cells Contributes to Their Enhanced Immune Evasion
Mohammad Sultan et al.
STEM CELLS (2018)
Disruption of IFN-I Signaling Promotes HER2/Neu Tumor Progression and Breast Cancer Stem Cells
Luciano Castiello et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Programmed cell removal by calreticulin in tissue homeostasis and cancer
Mingye Feng et al.
NATURE COMMUNICATIONS (2018)
CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer
Weilong Chen et al.
PLOS BIOLOGY (2018)
In Vivo Expansion of Cancer Stemness Affords Novel Cancer Stem Cell Targets: Malignant Rhabdoid Tumor as an Example
Hana Golan et al.
STEM CELL REPORTS (2018)
Co-culture of dendritic cells and cytokine-induced killer cells effectively suppresses liver cancer stem cell growth by inhibiting pathways in the immune system
Tao Yang et al.
BMC CANCER (2018)
Systemic Therapy for Hepatocellular Carcinoma: Latest Advances
Masatoshi Kudo
CANCERS (2018)
Cytokine-Induced Killer Cells Kill Chemo-surviving Melanoma Cancer Stem Cells
Loretta Gammaitoni et al.
CLINICAL CANCER RESEARCH (2017)
PSME3 induces epithelial-mesenchymal transition with inducing the expression of CSC markers and immunosuppression in breast cancer
Ziying Yi et al.
EXPERIMENTAL CELL RESEARCH (2017)
Cell Culture System for Analysis of Genetic Heterogeneity Within Hepatocellular Carcinomas and Response to Pharmacologic Agents
Qiang Gao et al.
GASTROENTEROLOGY (2017)
Evidence of lateral transmission of aggressive features between different types of breast cancer cells
Nancy Adriana Espinoza-Sanchez et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2017)
CIK as therapeutic agents against tumors
M. Introna
JOURNAL OF AUTOIMMUNITY (2017)
IFN-γ-related mRNA profile predicts clinical response to PD-1 blockade
Mark Ayers et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Prognostic value of stromal tumour infiltrating lymphocytes and programmed cell death-ligand 1 expression in breast cancer
Antonio Polonia et al.
JOURNAL OF CLINICAL PATHOLOGY (2017)
Circumventing intratumoral heterogeneity to identify potential therapeutic targets in hepatocellular carcinoma
Ao Huang et al.
JOURNAL OF HEPATOLOGY (2017)
Normal and cancerous mammary stem cells evade interferon-induced constraint through the miR-199a-LCOR axis
Toni Celia-Terrassa et al.
NATURE CELL BIOLOGY (2017)
Epigenetic therapy regulates the expression of ALDH1 and immunologic response: Relevance to the prognosis of oral cancer
Ming-Shao Tsai et al.
ORAL ONCOLOGY (2017)
Effect of dendritic cell-cytokine-induced killer cells in patients with advanced colorectal cancer combined with first-line treatment
Yunqing Xie et al.
WORLD JOURNAL OF SURGICAL ONCOLOGY (2017)
Serglycin as a potential biomarker for glioma: association of serglycin expression, extent of mast cell recruitment and glioblastoma progression
Ananya Roy et al.
ONCOTARGET (2017)
API5 confers cancer stem cell-like properties through the FGF2-NANOG axis
K-H Song et al.
ONCOGENESIS (2017)
CD59 Regulation by SOX2 Is Required for Epithelial Cancer Stem Cells to Evade Complement Surveillance
Jianfeng Chen et al.
STEM CELL REPORTS (2017)
Electrical brain stimulation induces dendritic stripping but improves survival of silent neurons after optic nerve damage
Petra Henrich-Noack et al.
SCIENTIFIC REPORTS (2017)
Surface PD-L1, E-cadherin, CD24, and VEGFR2 as markers of epithelial cancer stem cells associated with rapid tumorigenesis
Goodwin G. Jinesh et al.
SCIENTIFIC REPORTS (2017)
The KMT1A-GATA3-STAT3 Circuit Is a Novel Self-Renewal Signaling of Human Bladder Cancer Stem Cells
Zhao Yang et al.
CLINICAL CANCER RESEARCH (2017)
Qa-2 expression levels is related with tumor-infiltrating lymphocytes profile during solid Ehrlich tumor development
Istefani Luciene da Silva et al.
BIOMEDICINE & PHARMACOTHERAPY (2017)
Tumor-associated myeloid cells as guiding forces of cancer cell stemness
Antonio Sica et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
LILRB receptor-mediated regulation of myeloid cell maturation and function
William van der Touw et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2017)
Human U87 glioblastoma cells with stemness features display enhanced sensitivity to natural killer cell cytotoxicity through altered expression of NKG2D ligand
Se-Jeong Oh et al.
CANCER CELL INTERNATIONAL (2017)
CD73 as a therapeutic target for pancreatic neuroendocrine tumor stem cells
Eriko Katsuta et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
HepG2 cells acquire stem cell-like characteristics after immune cell stimulation
Hang Wang et al.
CELLULAR ONCOLOGY (2016)
A comparison of cancer stem cell markers and nonclassical major histocompatibility complex antigens in colorectal tumor and noncancerous tissues
Rabia Bilge Ozgul Ozdemir et al.
ANNALS OF DIAGNOSTIC PATHOLOGY (2016)
CD133+liver cancer stem cells resist interferon-gamma-induced autophagy
Jian Li et al.
BMC CANCER (2016)
Cathepsin G-mediated proteolytic degradation of MHC class I molecules to facilitate immune detection of human glioblastoma cells
David Palesch et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2016)
Ly6E/K Signaling to TGFβ Promotes Breast Cancer Progression, Immune Escape, and Drug Resistance
Midrar AlHossiny et al.
CANCER RESEARCH (2016)
Calreticulin is highly expressed in pancreatic cancer stem-like cells
Satoshi Matsukuma et al.
CANCER SCIENCE (2016)
CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1
Yunqin Lee et al.
CLINICAL CANCER RESEARCH (2016)
The analysis of estrogen receptor-α positive breast cancer stem-like cells unveils a high expression of the serpin proteinase inhibitor PI-9: Possible regulatory mechanisms
Marianna Lauricella et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2016)
The C-Terminal Acidic Region of Calreticulin Mediates Phosphatidylserine Binding and Apoptotic Cell Phagocytosis
Sanjeeva Joseph Wijeyesakere et al.
JOURNAL OF IMMUNOLOGY (2016)
Enhanced killing of chordoma cells by antibody-dependent cell-mediated cytotoxicity employing the novel anti-PD-L1 antibody avelumab
Rika Fujii et al.
ONCOTARGET (2016)
A New Biological Feature of Natural Killer Cells: The Recognition of Solid Tumor-Derived Cancer Stem Cells
Rossana Tallerico et al.
FRONTIERS IN IMMUNOLOGY (2016)
The role of CCL20/CCR6 axis in recruiting Treg cells to tumor sites of NSCLC patients
Chun-yang Zhang et al.
BIOMEDICINE & PHARMACOTHERAPY (2015)
Live cell evaluation of granzyme delivery and death receptor signaling in tumor cells targeted by human natural killer cells
Alexandra C. Vrazo et al.
BLOOD (2015)
Role of HLA-G and extracellular vesicles in renal cancer stem cell-induced inhibition of dendritic cell differentiation
Cristina Grange et al.
BMC CANCER (2015)
Cyclooxygenase-Dependent Tumor Growth through Evasion of Immunity
Santiago Zelenay et al.
CELL (2015)
Cancer stem cells and the tumor microenvironment: interplay in tumor heterogeneity
Adriana Albini et al.
CONNECTIVE TISSUE RESEARCH (2015)
Microenvironmental hCAP-18/LL-37 promotes pancreatic ductal adenocarcinoma by activating its cancer stem cell compartment
Bruno Sainz et al.
GUT (2015)
NK Cells Preferentially Target Tumor Cells with a Cancer Stem Cell Phenotype
Erik Ames et al.
JOURNAL OF IMMUNOLOGY (2015)
B7-H1 enhances proliferation ability of gastric cancer stem-like cells as a receptor
Yupeng Yang et al.
ONCOLOGY LETTERS (2015)
Cytokine-induced killer cells efficiently kill stem-like cancer cells of nasopharyngeal carcinoma via the NKG2D-ligands recognition
Fang Wei et al.
ONCOTARGET (2015)
Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin
Ling-Yen Chung et al.
ONCOTARGET (2015)
ANGPTL2/LILRB2 signaling promotes the propagation of lung cancer cells
Xiaoye Liu et al.
ONCOTARGET (2015)
Therapeutic potential and challenges of natural killer cells in treatment of solid tumors
Andrea Gras Navarro et al.
FRONTIERS IN IMMUNOLOGY (2015)
CD200: Association with cancer stem cell features and response to chemoradiation in head and neck squamous cell carcinoma
Yuh-Seog Jung et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)
IL-6 enriched lung cancer stem-like cell population by inhibition of cell cycle regulators via DNMT1 upregulation
Chen-Chi Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2015)
An Immunocompetent Mouse Model for MLL/AF9 Leukemia Reveals the Potential of Spontaneous Cytotoxic T-Cell Response to an Antigen Expressed in Leukemia Cells
Kana Hasegawa et al.
PLOS ONE (2015)
uPAR Induces Expression of Transforming Growth Factor beta and Interleukin-4 in Cancer Cells to Promote Tumor-Permissive Conditioning of Macrophages
Jingjing Hu et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Leukemia cell-targeted STAT3 silencing and TLR9 triggering generate systemic antitumor immunity
Dewan Md Sakib Hossain et al.
BLOOD (2014)
Cytokine-Induced Killer Cells Eradicate Bone and Soft-Tissue Sarcomas
Dario Sangiolo et al.
CANCER RESEARCH (2014)
API5 Confers Tumoral Immune Escape through FGF2-Dependent Cell Survival Pathway
Kyung Hee Noh et al.
CANCER RESEARCH (2014)
Cancer Stem Cells in Prostate Cancer Chemoresistance
Jie Ni et al.
CURRENT CANCER DRUG TARGETS (2014)
Immunology of cancer stem cells in solid tumours. A review
Cristina Maccalli et al.
EUROPEAN JOURNAL OF CANCER (2014)
Influence of interferon-α on the expression of the cancer stem cell markers in pancreatic carcinoma cells
Yifan Zhu et al.
EXPERIMENTAL CELL RESEARCH (2014)
CD271 on Melanoma Cell Is an IFN-γ-Inducible Immunosuppressive Factor that Mediates Downregulation of Melanoma Antigens
Junpei Furuta et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
Identification of Novel Human Leukocyte Antigen-A*0201-Restricted, Cytotoxic T Lymphocyte Epitopes on CD133 for Cancer Stem Cell Immunotherapy
Jianfei Ji et al.
STEM CELLS TRANSLATIONAL MEDICINE (2014)
Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape?
Valentin S. Bruttel et al.
FRONTIERS IN IMMUNOLOGY (2014)
Tumor-Associated Macrophages as Major Players in the Tumor Microenvironment
Theerawut Chanmee et al.
CANCERS (2014)
Autologous anti-SOX2 antibody responses reflect intensity but not frequency of antigen expression in small cell lung cancer
Sukru Atakan et al.
BMC CLINICAL PATHOLOGY (2014)
Protective Roles of Epithelial Cells in the Survival of Adult T-Cell Leukemia/Lymphoma Cells
Yukiko Miyatake et al.
AMERICAN JOURNAL OF PATHOLOGY (2013)
Antibody targeting of CD24 efficiently retards growth and influences cytokine milieu in experimental carcinomas
A. V. Salnikov et al.
BRITISH JOURNAL OF CANCER (2013)
Tumor-associated neutrophils (TAN) develop pro-tumorigenic properties during tumor progression
Inbal Mishalian et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
Characterization of small spheres derived from various solid tumor cell lines: are they suitable targets for T cells?
Antonia Busse et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Selections of appropriate regimen of high-dose chemotherapy combined with adoptive cellular therapy with dendritic and cytokine-induced killer cells improved progression-free and overall survival in patients with metastatic breast cancer: reargument of such contentious therapeutic preferences
Jun Ren et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2013)
Effective Activity of Cytokine-Induced Killer Cells against Autologous Metastatic Melanoma Including Cells with Stemness Features
Loretta Gammaitoni et al.
CLINICAL CANCER RESEARCH (2013)
Cellular therapy of cancer with natural killer cells-where do we stand?
Hans G. Klingemann
CYTOTHERAPY (2013)
Effects and Mechanisms of Anti-CD44 Monoclonal Antibody A3D8 on Proliferation and Apoptosis of Sphere-Forming Cells With Stemness From Human Ovarian Cancer
Yong-Rui Du et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2013)
Susceptibility to cytotoxic T cell lysis of cancer stem cells derived from cervical and head and neck tumor cell lines
Tian Liao et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
Human NK Cells Selective Targeting of Colon Cancer-Initiating Cells: A Role for Natural Cytotoxicity Receptors and MHC Class I Molecules
Rossana Tallerico et al.
JOURNAL OF IMMUNOLOGY (2013)
High CCR6/CCR7 expression and Foxp3+ Treg cell number are positively related to the progression of laryngeal squamous cell carcinoma
Bin Chen et al.
ONCOLOGY REPORTS (2013)
Blockade of A2A receptors potently suppresses the metastasis of CD73+ tumors
Paul A. Beavis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection
Elizabeth B. Wilson et al.
SCIENCE (2013)
Persistent LCMV Infection Is Controlled by Blockade of Type I Interferon Signaling
John R. Teijaro et al.
SCIENCE (2013)
Human mesenchymal stem cells creating an immunosuppressive environment and promote breast cancer in mice
Biljana Ljujic et al.
SCIENTIFIC REPORTS (2013)
Role of non-classical MHC class I molecules in cancer immunosuppression
Grazyna Kochan et al.
ONCOIMMUNOLOGY (2013)
Functional OCT4-specific CD4+ and CD8+ T cells in healthy controls and ovarian cancer patients
Jiabo Di et al.
ONCOIMMUNOLOGY (2013)
Aiming to immune elimination of ovarian cancer stem cells
Jiabo Di
World Journal of Stem Cells (2013)
Mechanisms of chemoresistance in cancer stem cells
Lissa Nurrul Abdullah et al.
CLINICAL AND TRANSLATIONAL MEDICINE (2013)
Susceptibility of CD24+ ovarian cancer cells to anti-cancer drugs and natural killer cells
Jiae Koh et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Human Glioblastoma Stem-Like Cells are More Sensitive to Allogeneic NK and T Cell-Mediated Killing Compared with Serum-Cultured Glioblastoma Cells
Tony Avril et al.
BRAIN PATHOLOGY (2012)
Sensitivity of a novel model of mammary cancer stem cell-like cells to TNF-related death pathways
Ming Li et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Immunomonitoring Results of a Phase II/III Study of Malignant Ascites Patients Treated with the Trifunctional Antibody Catumaxomab (Anti-EpCAM x Anti-CD3)
Michael Jaeger et al.
CANCER RESEARCH (2012)
Cancer Vaccination Drives Nanog-Dependent Evolution of Tumor Cells toward an Immune-Resistant and Stem-like Phenotype
Kyung Hee Noh et al.
CANCER RESEARCH (2012)
Full-length HLA-G1 and truncated HLA-G3 differentially increase HLA-E surface localization
Takele Teklemariam et al.
HUMAN IMMUNOLOGY (2012)
Nanog signaling in cancer promotes stem-like phenotype and immune evasion
Kyung Hee Noh et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
HLA-E contributes to an immune-inhibitory phenotype of glioblastoma stem-like cells
Fabian Wolpert et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development
Junke Zheng et al.
NATURE (2012)
Natural Killer Cells Preferentially Target Cancer Stem Cells; Role of Monocytes in Protection Against NK Cell Mediated Lysis of Cancer Stem Cells
Anahid Jewett et al.
CURRENT DRUG DELIVERY (2012)
Clinical Significance of the HLA-E and CD94/NKG2 Interaction
Milena Iwaszko et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2011)
Novel Role for STAT3 in Transcriptional Regulation of NK Immune Cell Targeting Receptor MICA on Cancer Cells
Romain Bedel et al.
CANCER RESEARCH (2011)
Human CD271-Positive Melanoma Stem Cells Associated with Metastasis Establish Tumor Heterogeneity and Long-term Growth
Gianluca Civenni et al.
CANCER RESEARCH (2011)
Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention?
Laurence Amiot et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2011)
Glioma-Associated Cytomegalovirus Mediates Subversion of the Monocyte Lineage to a Tumor Propagating Phenotype
Kristine Dziurzynski et al.
CLINICAL CANCER RESEARCH (2011)
IMMUNOREGULATORY PROPERTIES OF CD44+CANCER STEM-LIKE CELLS IN SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK
Kazuaki Chikamatsu et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2011)
Immunotherapy targeting colon cancer stem cells
Flora Iovino et al.
IMMUNOTHERAPY (2011)
Breast cancer stem cells, cytokine networks, and the tumor microenvironment
Hasan Korkaya et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Melanoma stem cells: not rare, but well done
Sasha D. Girouard et al.
LABORATORY INVESTIGATION (2011)
Melanoma Spheroids Grown Under Neural Crest Cell Conditions Are Highly Plastic Migratory/Invasive Tumor Cells Endowed with Immunomodulator Function
Kiran Ramgolam et al.
PLOS ONE (2011)
Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
Robert D. Schreiber et al.
SCIENCE (2011)
Tumor Initiation in Human Malignant Melanoma and Potential Cancer Therapies
Jie Ma et al.
ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY (2010)
Phenotypic Heterogeneity among Tumorigenic Melanoma Cells from Patients that Is Reversible and Not Hierarchically Organized
Elsa Quintana et al.
CANCER CELL (2010)
Spheres derived from the human SK-RC-42 renal cell carcinoma cell line are enriched in cancer stem cells
Yong Zhong et al.
CANCER LETTERS (2010)
Cell Signaling by Urokinase-type Plasminogen Activator Receptor Induces Stem Cell-like Properties in Breast Cancer Cells
Minji Jo et al.
CANCER RESEARCH (2010)
Definition of an Enhanced Immune Cell Therapy in Mice That Can Target Stem-Like Lymphoma Cells
Christopher H. Contag et al.
CANCER RESEARCH (2010)
Modulation of T-Cell Activation by Malignant Melanoma Initiating Cells
Tobias Schatton et al.
CANCER RESEARCH (2010)
Transcriptional Profiles of CD133(+) and CD133(-) Glioblastoma-Derived Cancer Stem Cell Lines Suggest Different Cells of Origin
Claudio Lottaz et al.
CANCER RESEARCH (2010)
Metformin against TGFβ-induced epithelial-to-mesenchymal transition (EMT) From cancer stem cells to aging-associated fibrosis
Silvia Cufi et al.
CELL CYCLE (2010)
Metformin regulates breast cancer stem cell ontogeny by transcriptional regulation of the epithelial-mesenchymal transition (EMT) status
Alejandro Vazquez-Martin et al.
CELL CYCLE (2010)
SIP1 Mediates Cell-Fate Decisions between Neuroectoderm and Mesendoderm in Human Pluripotent Stem Cells
Zhenzhi Chng et al.
CELL STEM CELL (2010)
Immunobiological Characterization of Cancer Stem Cells Isolated from Glioblastoma Patients
Tiziano Di Tomaso et al.
CLINICAL CANCER RESEARCH (2010)
The role of CD200 in immunity to B cell lymphoma
Karrie K. Wong et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2010)
Glioblastoma Cancer-Initiating Cells Inhibit T-Cell Proliferation and Effector Responses by the Signal Transducers and Activators of Transcription 3 Pathway
Jun Wei et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271
Alexander D. Boiko et al.
NATURE (2010)
Glioma cancer stem cells induce immunosuppressive macrophages/microglia
Adam Wu et al.
NEURO-ONCOLOGY (2010)
T Cells Enhance Stem-Like Properties and Conditional Malignancy in Gliomas
Dwain K. Irvin et al.
PLOS ONE (2010)
Antitumor Immunity and Cancer Stem Cells
Tobias Schatton et al.
HEMATOPOIETIC STEM CELLS VII (2009)
Transforming growth factor-beta signaling: emerging stem cell target in metastatic breast cancer?
Antoinette R. Tan et al.
BREAST CANCER RESEARCH AND TREATMENT (2009)
Immunoselection of Breast and Ovarian Cancer Cells with Trastuzumab and Natural Killer Cells: Selective Escape of CD44high/CD24low/HER2low Breast Cancer Stem Cells
Florian Reim et al.
CANCER RESEARCH (2009)
Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells
Marta Santisteban et al.
CANCER RESEARCH (2009)
NK Cells Recognize and Kill Human Glioblastoma Cells with Stem Cell-Like Properties
Roberta Castriconi et al.
JOURNAL OF IMMUNOLOGY (2009)
Soluble Mediators From Human Neural Stem Cells Play a Critical Role in Suppression of T-Cell Activation and Proliferation
Su-Young Kim et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
Molecular pathological approaches to human tumor immunology
Noriyuki Sato et al.
PATHOLOGY INTERNATIONAL (2009)
Expansion of CD133-Expressing Liver Cancer Stem Cells in Liver-Specific Phosphatase and Tensin Homolog Deleted on Chromosome 10-Deleted Mice
C. Bart Rountree et al.
STEM CELLS (2009)
Zebrafish as a Model for Cancer Self-Renewal
Myron S. Ignatius et al.
ZEBRAFISH (2009)
Death by a thousand cuts: Granzyme pathways of programmed cell death
Dipanjan Chowdhury et al.
ANNUAL REVIEW OF IMMUNOLOGY (2008)
The epithelial-mesenchymal transition generates cells with properties of stem cells
Sendurai A. Mani et al.
CELL (2008)
Efficient tumour formation by single human melanoma cells
Elsa Quintana et al.
NATURE (2008)
Cancer stem cells, CD200 and immunoevasion
Brian T. Kawasaki et al.
TRENDS IN IMMUNOLOGY (2008)
Co-expression of the toleragenic glycoprotein, CD200, with markers for cancer stem cells
Brian T. Kawasaki et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Both CD133+ and CD133- medulloblastoma cell lines express ligands for triggering NK receptors and are susceptible to NK-mediated cytotoxicity
Roberta Castriconi et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2007)
Chemotherapy-resistant side-population of colon cancer cells has a higher sensitivity to TRAIL than the non-SP, a higher expression of c-Myc and TRAIL-receptor DR4
Robyn T. Sussman et al.
CANCER BIOLOGY & THERAPY (2007)
Frequent and specific immunity to the embryonal stem cell-associated antigen SOX2 in patients with monoclonal gammopathy
Radek Spisek et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Molecular definition of breast tumor heterogeneity
Michail Shipitsin et al.
CANCER CELL (2007)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
CD200 as a prognostic factor in acute myeloid leukaemia
A. Tonks et al.
LEUKEMIA (2007)
Targeting of CD44 eradicates human acute myeloid leukemic stem cells
Liqing Jin et al.
NATURE MEDICINE (2006)
Mechanisms of pericyte recruitment in tumour angiogenesis: A new role for metalloproteinases
CF Chantrain et al.
EUROPEAN JOURNAL OF CANCER (2006)
Human leukocyte antigen and antigen processing machinery component defects in astrocytic tumors
A Facoetti et al.
CLINICAL CANCER RESEARCH (2005)
Perforin triggers a plasma membrane-repair response that facilitates CTL induction of apoptosis
D Keefe et al.
IMMUNITY (2005)
A novel mechanism for protein delivery -: Granzyme B undergoes electrostatic exchange from serglycin to target cells
SM Raja et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Downregulation of major histocompatibility complex antigens in invading glioma cells: stealth invasion of the brain
D Zagzag et al.
LABORATORY INVESTIGATION (2005)
Elevated TGF-β1 secretion and down-modulation of NKG2D underlies impaired NK cytotoxicity in cancer patients
JC Lee et al.
JOURNAL OF IMMUNOLOGY (2004)
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells
K Le Blanc et al.
EXPERIMENTAL HEMATOLOGY (2003)
Prospective identification of tumorigenic breast cancer cells
M Al-Hajj et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
CD200 and membrane protein E interactions in the control of myeloid cells
AN Barclay et al.
TRENDS IN IMMUNOLOGY (2002)
Perforin lytic activity is controlled by calreticulin
SA Fraser et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
